Exicure, Inc. Faces Delisting Concerns
Ticker: XCUR · Form: 8-K · Filed: May 23, 2024 · CIK: 1698530
| Field | Detail |
|---|---|
| Company | Exicure, Inc. (XCUR) |
| Form Type | 8-K |
| Filed Date | May 23, 2024 |
| Risk Level | high |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, sec-filing
TL;DR
Exicure's stock might get delisted, check the exchange rules.
AI Summary
Exicure, Inc. filed an 8-K on May 23, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company's principal executive offices are located at 2430 N. Halsted St., Chicago, IL 60614.
Why It Matters
This filing indicates potential issues with Exicure, Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- Exicure, Inc. (company) — Registrant
- 2430 N. Halsted St., Chicago, IL 60614 (location) — Principal Executive Offices
- May 23, 2024 (date) — Filing Date
- May 21, 2024 (date) — Earliest Event Reported
FAQ
What is the specific reason for Exicure, Inc.'s potential delisting?
The filing states it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing,' but the specific rule or standard is not detailed in this excerpt.
When was this 8-K form filed with the SEC?
The 8-K form was filed on May 23, 2024.
What is the address of Exicure, Inc.'s principal executive offices?
The principal executive offices are located at 2430 N. Halsted St., Chicago, IL 60614.
What is Exicure, Inc.'s Commission File Number?
Exicure, Inc.'s Commission File Number is 001-39011.
What is the earliest event date reported in this filing?
The earliest event date reported is May 21, 2024.
Filing Stats: 1,104 words · 4 min read · ~4 pages · Grade level 14.1 · Accepted 2024-05-23 16:18:08
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share XCUR The Nasdaq Stock Market
Filing Documents
- xcur-20240521.htm (8-K) — 33KB
- aex991pressreleasemay232024.htm (EX-99.1) — 10KB
- exicureimage1a10.gif (GRAPHIC) — 3KB
- 0001698530-24-000034.txt ( ) — 173KB
- xcur-20240521.xsd (EX-101.SCH) — 2KB
- xcur-20240521_lab.xml (EX-101.LAB) — 21KB
- xcur-20240521_pre.xml (EX-101.PRE) — 12KB
- xcur-20240521_htm.xml (XML) — 3KB
01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 21, 2024, Exicure, Inc. (the " Company ") received notice of a delisting determination (the " Staff Delisting Determination ") from the Listing Qualifications Department of The Nasdaq Stock Market LLC (" Nasdaq "). The Staff Delisting Determination notified the Company that since it has not yet filed its Form 10-K for the year ended December 31, 2023 (the " Form 10-K ") per Nasdaq Listing Rule 5250(c)(1) (the " Rule ") by Nasdaq's extended deadline of May 20, 2024 pursuant to the previously granted exception, trading of the Company's common stock would be suspended from The Nasdaq Capital Market at the opening of business on May 30, 2024, unless the Company requests an appeal of the Staff Delisting Determination by May 28, 2024. In addition, unless an appeal is timely requested, a Form 25-NSE would be filed with the Securities and Exchange Commission (the "SEC"), which would remove the Company's securities from listing and registration on Nasdaq. In addition to the delinquency related to the Form 10-K, the Staff Delisting Determination noted the Company's delinquency under the Rule because of its failure to file its Form 10-Q for the first quarter of 2024 (the " Q1 Form 10-Q ") and the Company's continued delinquency under Rule 5620 because it has not held its 2023 Annual Meeting of Stockholders, each as an additional and separate basis for delisting that should be addressed in any appeal. The Company intends to file an appeal to Nasdaq's Hearings Panel by the May 28, 2024 deadline and subsequently submit its plan to regain compliance with all applicable listing requirements. This request for an appeal, if timely submitted, would automatically stay the suspension of trading in the Company's securities for a period of 15 days from the date of the request. The Company intends to seek an extended stay pending the hearing, although no assurance can b
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated May 23, 2024 104 Cover Page Interactive Data File (Embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 23, 2024 EXICURE, INC. (registrant) By: /s/ Paul Kang Paul Kang Chief Executive Officer